IP Library Granted Patent US 9,867,685
Granted Patent B2
US 9,867,685 · App. 14/697,525 · Granted Jan 16, 2018

Minimally invasive implant and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,867,685
App. No.
14/697,525
Granted
Jan 16, 2018
Kind
B2
Abstract

Apparatus and methods are provided for treating urinary incontinence, fecal incontinence, and other pelvic defects or dysfunctions, in both males and females, using one or more lateral implants to reinforce the supportive tissue of the urethra. The implants can be configured as a sling device having at least one extension arm and a tissue support portion having an eyelet, wherein a portion of the at least one extension arm is adapted to slide through and adjustably attach with the eyelet.

Claims (19)

1. An elongate implantable incontinence sling system, comprising:

a tissue support portion having a first eyelet and a second eyelet;

a first extension arm having a mesh extension, a first anchor portion, and a first rod member, with at least a length of the first extension arm adapted to slide through the first eyelet of the tissue support portion; and

a second extension arm having a second anchor portion and a second rod member, with at least a length of the second extension arm adapted to slide through the second eyelet of the tissue support portion.

2. The sling system of claim 1 , wherein at least a portion of the second extension arm is constructed of a mesh material.

3. The sling system of claim 1 , wherein at least one of the first and second rod members is a polymer extension rod.

4. The sling system of claim 1 , wherein the first and second rod members are polymer extension rods.

5. The sling system of claim 1 , further including a grommet adapted to engage at least one of the first and second eyelets to facilitate attachment of the first extension arm or the second extension arm.

6. The sling system of claim 1 , further including one or more alignment indicia provided along a portion of the tissue support portion.

7. The sling system of claim 6 , wherein the one or more indicia includes three indicia adapted to guide placement of the elongate sling relative to tissue targeted for support.

8. The sling system of claim 1 , wherein the anchor portion of at least one of the first and second extension arms is adapted to engage with obturator tissue.

9. The sling system of claim 1 , wherein the anchor portion of at least one of the first and second extension arms is adapted to engage with rectus fascia.

10. The sling system of claim 1 , wherein the tissue support portion spans under and provides support to the urethra.

11. An elongate implantable incontinence sling system, comprising:

a tissue support portion having a first eyelet and a second eyelet;

a first extension arm having a first anchor portion, an elongate first mesh portion, and a first rod member, with at least a length of the first elongate mesh portion adapted to slide through the first eyelet of the tissue support portion; and

a second extension arm having a second anchor portion, a second elongate mesh portion, and a second rod member, with at least a length of the second elongate mesh portion adapted to slide through the second eyelet of the tissue support portion, such that the tissue support portion spans under and provides support to the urethra.

12. The sling system of claim 11 , further including a grommet adapted to engage at least one of the first and second eyelets to facilitate attachment of the first extension arm or the second extension arm.

13. The sling system of claim 11 , further including one or more alignment indicia provided along a portion of the tissue support portion.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →